AI Science Tracker
EN

Constructing custom-made radiotranscriptomic signatures of vascular inflammation from routine CT angiograms: a prospective outcomes validation study in COVID-19.

University of Oxford · 26 Aug 2022 · medicine

Discovery

Constructing custom-made radiotranscriptomic signatures of vascular inflammation from routine CT angiograms: a prospective outcomes validation study in COVID-19.

Source check: Source checked. Not independent scientific confirmation.

Finding: An XGBoost radiotranscriptomic signature is derived from CT angiography and linked vascular transcriptomic samples, then validated for COVID-19 mortality across several prospective patient cohorts. External replication and prospective utility were not established in the reviewed material.

Technology: Independent patient cohorts, varying CT protocols, and mortality outcomes provide validation; retrospective pandemic setting and subgroup/treatment confounding limit causal interpretation.

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
Independent patient cohorts, varying CT protocols, and mortality outcomes provide validation; retrospective pandemic setting and subgroup/treatment confounding limit causal interpretation.
Test and result
An XGBoost radiotranscriptomic signature is derived from CT angiography and linked vascular transcriptomic samples, then validated for COVID-19 mortality across several prospective patient cohorts.
Limitation / still unknown
External replication, causal effects and prospective utility were not established in the reviewed material.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://europepmc.org/article/MED/36038496

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.